Irie Junichiro, Itoh Hiroshi
Division of Endocrinology, Metabolism and Nephrology, Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan.
Clin Calcium. 2017;27(7):983-990.
Sirtuins are NAD-dependent deacetylase and have drawn much attention as important regulators of aging and longevity. Because NAD decline during the aging process, the approach to regulating aging using NAD precursor such as nicotinamide mononucleotide (NMN) to replenish cellular NAD through the activation of sirtuins have been investigated. In various animal models, NMN has been shown to mitigate age-associated physiological changes in liver, adipose tissue, muscle, pancreas, kidney, retina, and central nerve system. In animal models of metabolic diseases, NMN has been demonstrated to improve obesity, insulin resistance, and muscle mitochondrial dysfunction. In this review, recent findings in the NMN research will be summarized, and the potential of NMN on the regulation of age-associated diseases in humans will be discussed.
沉默调节蛋白是依赖烟酰胺腺嘌呤二核苷酸(NAD)的脱乙酰酶,作为衰老和长寿的重要调节因子备受关注。由于衰老过程中NAD水平会下降,因此人们研究了使用烟酰胺单核苷酸(NMN)等NAD前体来补充细胞内NAD,从而通过激活沉默调节蛋白来调控衰老的方法。在各种动物模型中,NMN已被证明可减轻肝脏、脂肪组织、肌肉、胰腺、肾脏、视网膜和中枢神经系统中与年龄相关的生理变化。在代谢性疾病的动物模型中,NMN已被证明可改善肥胖、胰岛素抵抗和肌肉线粒体功能障碍。在本综述中,将总结NMN研究的最新发现,并讨论NMN对人类年龄相关疾病的调控潜力。